Susan Eaton

1.4k total citations
28 papers, 1.0k citations indexed

About

Susan Eaton is a scholar working on Neurology, Epidemiology and Surgery. According to data from OpenAlex, Susan Eaton has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 8 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Susan Eaton's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (7 papers) and Restless Legs Syndrome Research (5 papers). Susan Eaton is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (7 papers) and Restless Legs Syndrome Research (5 papers). Susan Eaton collaborates with scholars based in United States, Germany and United Kingdom. Susan Eaton's co-authors include Tjeerd van Staa, Tim Williams, Shivani Puri, Janet Benesh, Krai Chatamra, Liam Smeeth, Coleen Hall, John T. Slevin, Kourtney J. Davis and John R. Hurst and has published in prestigious journals such as Blood, Neurology and Cancer.

In The Last Decade

Susan Eaton

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Eaton United States 15 323 253 206 137 128 28 1.0k
Gregory Lenhart United States 18 233 0.7× 232 0.9× 106 0.5× 67 0.5× 42 0.3× 52 1.1k
Nahara Anani Martínez-González Switzerland 15 136 0.4× 245 1.0× 75 0.4× 109 0.8× 130 1.0× 21 1.1k
Erwin Chiquete Mexico 16 554 1.7× 501 2.0× 134 0.7× 43 0.3× 64 0.5× 128 1.2k
Karyn Butler United States 17 142 0.4× 135 0.5× 153 0.7× 38 0.3× 130 1.0× 41 967
Jay Meyer United States 8 167 0.5× 338 1.3× 321 1.6× 228 1.7× 36 0.3× 12 1.0k
Victoria McCredie Canada 17 451 1.4× 231 0.9× 252 1.2× 19 0.1× 81 0.6× 59 1.1k
Cynthia Bell United States 20 57 0.2× 139 0.5× 199 1.0× 124 0.9× 211 1.6× 84 1.5k
Yung‐Cheng Su Taiwan 14 182 0.6× 228 0.9× 107 0.5× 38 0.3× 75 0.6× 44 711
Vidhu Anand United States 18 55 0.2× 130 0.5× 235 1.1× 155 1.1× 93 0.7× 53 924
Farid Sadaka United States 15 244 0.8× 379 1.5× 84 0.4× 35 0.3× 65 0.5× 51 846

Countries citing papers authored by Susan Eaton

Since Specialization
Citations

This map shows the geographic impact of Susan Eaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Eaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Eaton more than expected).

Fields of papers citing papers by Susan Eaton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Eaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Eaton. The network helps show where Susan Eaton may publish in the future.

Co-authorship network of co-authors of Susan Eaton

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Eaton. A scholar is included among the top collaborators of Susan Eaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Eaton. Susan Eaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Proud, Crystal M., Qiang Hou, Emma Viscidi, et al.. (2023). Examining Real-World Adherence to Nusinersen for the Treatment of Spinal Muscular Atrophy Using Two Large US Data Sources. Advances in Therapy. 40(3). 1129–1140. 5 indexed citations
2.
Viscidi, Emma, Irene Litvan, Tien Dam, et al.. (2021). Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database. Frontiers in Neurology. 12. 571800–571800. 19 indexed citations
3.
Maserejian, Nancy N., et al.. (2021). Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis. Alzheimer s & Dementia. 17(7). 1231–1243. 16 indexed citations
4.
Viscidi, Emma, Maneesh Juneja, Jin Wang, et al.. (2021). Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched Controls. Neurology and Therapy. 11(1). 449–457. 4 indexed citations
5.
6.
Fernandez, Hubert H., James T. Boyd, Victor S.C. Fung, et al.. (2018). Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease. Movement Disorders. 33(6). 928–936. 69 indexed citations
7.
Murata, Miho, Masahito Mihara, Kazuko Hasegawa, et al.. (2016). Efficacy and safety of levodopa–carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson’s disease patients. npj Parkinson s Disease. 2(1). 16020–16020. 13 indexed citations
8.
Epstein, Michael, David A. Johnson, Robert H. Hawes, et al.. (2016). Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease. Clinical and Translational Gastroenterology. 7(3). e159–e159. 36 indexed citations
9.
Fernandez, Hubert H., Weining Robieson, Krai Chatamra, et al.. (2016). Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson’s disease. npj Parkinson s Disease. 2(1). 16015–16015. 8 indexed citations
10.
11.
Slevin, John T., Hubert H. Fernandez, Cindy Zadikoff, et al.. (2015). Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients. Journal of Parkinson s Disease. 5(1). 165–174. 85 indexed citations
12.
13.
Epstein, Michael, David H. Johnson, Robert H. Hawes, et al.. (2014). Gastrointestinal Safety of the Levodopa-Carbidopa Intestinal Gel Delivery System in Treating Advanced Parkinson’s Patients (P7.085). Neurology. 82(10_supplement). 2 indexed citations
14.
Quint, Jennifer K, Hana Müllerová, Rachael L. DiSantostefano, et al.. (2014). Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open. 4(7). e005540–e005540. 203 indexed citations
15.
Gruenigen, Vivian E. von, Robert M. Wenham, Heidi E. Frasure, et al.. (2014). Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer. Investigational New Drugs. 32(4). 729–738. 23 indexed citations
16.
Boggon, Rachael, Richard Hubbard, Liam Smeeth, et al.. (2013). Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study. BMC Pulmonary Medicine. 13(1). 32–32. 25 indexed citations
17.
Gruenigen, Vivian E. von, Heidi E. Frasure, Deborah A. Smith, et al.. (2012). Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies. Anti-Cancer Drugs. 23(7). 724–730. 5 indexed citations
18.
Gruenigen, Vivian von, Heidi E. Frasure, Nancy Fusco, et al.. (2010). A double‐blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin‐related hand‐foot syndrome in gynecologic oncology patients. Cancer. 116(20). 4735–4743. 43 indexed citations
19.
Devine, Scott, Suzanne L. West, Elizabeth Andrews, et al.. (2009). The identification of pregnancies within the general practice research database. Pharmacoepidemiology and Drug Safety. 19(1). 45–50. 54 indexed citations
20.
Martínez, Carlos, Henrik W. Finnern, Stephan Rietbrock, et al.. (2008). Patterns of treatment for restless legs syndrome in primary care in the United Kingdom. Clinical Therapeutics. 30(2). 405–418. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory Lenhart Breakdown of academic impact, for papers by Nahara Anani Martínez-González Breakdown of academic impact, for papers by Erwin Chiquete Breakdown of academic impact, for papers by Karyn Butler Breakdown of academic impact, for papers by Jay Meyer Breakdown of academic impact, for papers by Victoria McCredie Breakdown of academic impact, for papers by Cynthia Bell Breakdown of academic impact, for papers by Yung‐Cheng Su Breakdown of academic impact, for papers by Vidhu Anand Breakdown of academic impact, for papers by Farid Sadaka
Rankless by CCL
2026